Brief report: Risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults

Journal of Autism and Developmental Disorders

Volumn 27, Issue 4, 1997, Pages 479-489

  Khan, Barkat U ^a  

^a Gulf Coast Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADULT; AGGRESSION; BEHAVIOR DISORDER; BEHAVIOR MODIFICATION; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; IMPULSIVENESS; INJURY; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; REVIEW; TARDIVE DYSKINESIA;

ADULT; AGGRESSION; ANTIPSYCHOTIC AGENTS; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; NEUROLOGIC EXAMINATION; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; RISPERIDONE; SELF-INJURIOUS BEHAVIOR;

EID: 0030877739     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025813607005     Document Type: Review

References (28)

1. Apter, A., Van Praag, H. M., Plutchik, R., Sevy, S., Korn, M., & Brown, S-L. (1990). Interrelationships among anxiety, aggression, impulsivity, and mood: A sertonergically linked cluster? Psychiatric Research, 32, 191-199.
2. Brown, G. L., & Linnoila, M. I. (1990). CSDF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. Journal of Clinical Psychiatry, 51(Suppl. 4), 31-41.
3. Campbell, J. J., & Duffy, J. D. (1995). Sertraline treatment of aggression in a developmentally disabled patient. Journal of Clinical Psychiatry, 56, 123-124.
4. Casey, D. R., & Gerlach, J. (1986). Tardive dyskinesia: What is the longterm outcome? In D. E. Casey & G. Gardos (Eds.)., Tardive dyskinesia and neuroleptics: From dogma to reason (pp. 75-97). Washington, DC: American Psychiatric Press.
5. Cavallero, R., Ragazetti, M. G., Mundo, E., Brancato, V., & Smeraldi, E. (1993). Tardive dyskinesia outcomes: Clinical and pharmacological correlates of remission and persistence. Neuropsychopharmacology, 8, 233-239.
6. Chouinard, G. (1995). Effects of risperidone on tardive dyskinesia: An analysis of the Canadian multicenter risperidone study. Journal of Clinical Psychopharmacology, 15, 36S-44S.
7. Chouinard, G., Remington, G., Bloom, D., Addington, D., MacEwan, G. W., Labelle, A., Beauclair, L., & Arnott, W. (1993). A Canadian multicenter placebo-controlled study of fixed doses of risperidone had haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology, 13, 25-29.
8. Czobor, P., Voklava, D., & Meiback, R. (1995). Effect of risperidone on hostility in schizophrenia. Journal of Clinical Psychopharmacology, 15, 243-249.
9. Dalgalarrondo, P., & Gattaz, W. F. (1994). Basal ganglia abnormalities in tardive dyskinesia (TD). Possible relationship with duration of neuroleptic treatment. European Archives of Psychiatry and Clinical Neuroscience, 244, 272-277.
10. Fuller, F. A. (1995). Influence of fluoxetine on aggressive behavior. Neuropsychopharmacology, 14, 77-81.
11. Gardos, G., Casey, D. E., Cole, J. O., Perenyi, A., Kocsis, E., Arato, M., Samson, J. A., & Conley, C. (1994). Ten-year outcome of tardive dyskinesia. American Journal of Psychiatry, 151, 836-841.
12. Glazer, W. M., & Morgenstern, H. (1988). Predictors of occurrence, severity, and course of tardive dyskinesia in an outpatient population. Journal of Clinical Psychopharmacology, 8 (Suppl.), 10S-16S.
13. Golden, R. N., Gimore, J. H., Corrigan, M. H. N., Ekstrom, R. D., Knight, B. T., & Garbutt, J. C. (1991). Serotonin, suicide, and aggression: Clinical Studies. Journal of Clinical Psychiatry, 52(Suppl 12): 61-69.
14. Jeanblanc, W., & Davis, Y. B. (1995). Risperidone for treating dementia-associated aggression. American Journal of Psychiatry, 152, 1239.
15. Jeste, D. V., & Caligiuri, M. P. (1993). Tardive dyskinesia. Schizophrenia Bulletin, 19, 303-315.
16. Khan, R. S., Van Praag, H. M., Wetzler, S., Asnis, G. M., & Barr, G. (1988). Serotonin and anxiety revisited. Biological Psychiatry, 23, 189-208.
17. Kane, J. M., Woerner, M., Borenstein, M., Wegner, J., & Lieberman, J. (1986). Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacology Bulletin, 22, 254-258.
18. Kopala, L. V., & Honer, W. G. (1994). Schizophrenia and tardive dyskinesia responsive to risperidone. Journal of Clinical Psychopharmacology, 14, 430-431.
19. Kravitz, H. M., & Fawcett, J. (1994). Serenics for aggressive behavior. Psychiatric Annals, 24, 453-459.
20. McDougle, C. J., Brodkin, E. S., Yeung, P. P., Naylor, S. T., Cohen, D. J., & Price, L. H. (1995). Journal of Child and Adolescent Psychopharmacology, 5, 273-282.
21. Marder, S. R., & Meibach, R. C. (1994). Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825-834.
22. Purdon, S. E., Lit, W., Labelle, A., & Jones, B. D. W. (1994). Risperidone in the treatment of pervasive developmental disorder. Canadian Journal of Psychiatry, 39, 400-405.
23. Raheja, R. K., Bharwani, I., & Penetrante, A. E. (1995). Efficacy of risperidone for behavioral disorders in the elderly: A clinical observation. Journal of Geriatric Psychiatry and Neurology, 8, 159-161.
24. Reid, A. H., & Ballinger, E. R. (1995). Behavioral symptoms among severely and profoundly mentally retarded patients. British Journal of Psychiatry, 167, 452-455.
25. Shriqui, C., & Annable, L. (1995). Tardive dyskinesia. In C. L. Shriqui & H. A. Nasrallah (Eds.), Contemporary issues in the treatment of schizophrenia (pp. 585-632). Washington, DC: American Psychiatric Press.
26. Shriqui, C., Nobecourt, P., Rousseau, F., & Arnott, W. (1994). Clinical efficacy of risperidone in a patient with severe tardive dyskinesia. Schizophrenia Research 11, 94 (Abstract).
27. Simeon, J. G., Carrey, N. J., Wiggins, D. M., Milin, R. P., & Hosenbocus, S. N. (1995). Risperidone effects in treatment-resistant adolescents: Preliminary case reports. Journal of Child and Adolescent Psychopharmacology, 5, 69-79.
28. Tamminga, C. A., Thaker, G. K., Moran, M., Kakigi, T., & Gao, X. M. (1994). Clozapine in tardive dyskinesia: Observations from human and animal model studies. Journal of Clinical Psychiatry, 55(Suppl.B), 102-106.